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Conclusion
• Communication needs of users and potential barriers should be considered when planning to implement QCancer.
• Further research is needed to pilot and evaluate the impact of QCancer on outcomes such as rates of investigations, referrals, diagnosis as well 
as patient and practitioner experiences of using the tool.
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• Earlier detection of cancer may help 
reduce the current high level of cancer 
mortality in the UK. 
• Cancer risk assessment tools such as 
QCancer, which predict the absolute 
risk of cancer in symptomatic 
individuals, may help identify those at 
high risk needing investigation for 
possible cancer. 
• Little is known about the views of 
service users  and primary care 
practitioners on the use of  QCancer in 
primary care (PC) consultations. 
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We interviewed 36 participants (19 service users and 17 practitioners) until data saturation. 
Four main themes emerged:
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Method
Implications of quantifying cancer risk
using QCancer:
• Potential conflict with current cancer risk
guidelines.
• Need to refer patients with symptoms
suggestive of cancer whatever their
quantified risk.
e.g. Patients with symptoms suggestive of
cancer need referral:
“It doesn't really matter about
percentages; I know 1% is less risk. But
the fact is the symptom is there, the
coughing out of blood, which is quite
worrying” (Service User [SU]:13)
“As I said, if I suspect cancer and I put in
the tool 1%, 2% doesn't matter to me”
(Practitioner [P]:5)
Usefulness of QCancer:
• Quantify cancer risk
• Support clinical decision making
• Inform efforts to modify health behaviours
• Improve processes and speed of
assessments, diagnosis and treatment
• Enable practitioners to personalise patient
care.
e.g. Inform efforts to modify health
behaviours:
“To be forewarned is to be forearmed, so
they change their life styles such as stopping
smoking or drinking alcohol” (SU:10)
“I mean like someone who is a smoker, you
can use this tool to help them modify their
lifestyle. And people who are refusing
referral, you can use the tool to estimate
their risk to show and explain to them” (P:2)
Potential challenges with uptake
• Additional time required for its use and
communication
• Unnecessary worry relating to investigation
of false positives
• Potential for over-referral
• Practitioner scepticism
• Need to establish the effectiveness of
QCancer against current practice before
introducing it more widely.
e.g. Need for evidence before introducing 
QCancer in patient consultations:
I think if you are going to roll something out
rather than going to everybody I would start
with the doctors, see how the doctors do with
it after evaluation and then move on the
practice nurses (SU:12)
“It's almost like an ongoing research where
people use the tool and then say well
actually the 4% risk that we calculated, we
are sending 500 people and 1% is getting
diagnosed. Or actually it's an under estimate.
(P:1)
Enhancing patient-practitioner 
communication:
• Tailoring a visual representation of risk; 
• Being honest and open with patients
• Involving patients in the use of 
QCancer; 
• Allowing time for listening, explaining, 
informing and reassuring patients. 
e.g. Being honest and open with patients:
“When I go to the doctor I expect to be
honest with him and be clear as best as I
can and you would expect the same from
the practitioner, open conversation, open
details from both sides to avoid
misunderstanding” (SU:19)
“I will be quite open and honest with them
that, you've come with these symptoms,
some of them are already in, and we can
use the tool to work out what it is” (P:11)
To explore the perspectives of service
users and primary care practitioners on
use of QCancer and how to enhance
communication with patients when using
QCancer in PC consultations.
• The study was conducted in 
Lincolnshire, a large rural county in the 
East Midlands of the UK, using a 
qualitative research design. 
• This involved individual interviews with 
service users recruited from the 
general public, and both individual and 
focus group interviews with primary 
care practitioners, including general 
practitioners and practice nurses.
• Data were recorded, transcribed 
verbatim and analysed using the 
framework approach. 
• Ethics approval was granted by the 
University of Lincoln School of Health 
and Social Care Ethics Committee.
